JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home


*386 !**	Tue, 7/31/2012, 2:00 PM - 3:50 PM	HQ-Sapphire B
Simulations to Aid Novel Clinical Trial Designs and Analyses — Topic Contributed Papers
Committee on Applied Statisticians , Biopharmaceutical Section , Section for Statistical Programmers and Analysts , International Indian Statistical Association
Organizer(s): Amarjot Kaur, Merck Research Laboratories
Chair(s): Amarjot Kaur, Merck Research Laboratories
2:05 PM	Efficient Analyses of Phase II Dose-Range Trials to Optimize Phase III Trial Design — Devan Mehrotra, Merck Research Laboratories ; Robin Mogg, Merck Research Laboratories ; Jianchang Lin, Millennium: The Takeda Oncology Company
2:25 PM	Simulations in Forecasting Recruitment, Drug Supply, Event Occurrence, and Efficiency of Drug Development — James Bolognese, Cytel Inc. ; Nitin Patel, Cytel Inc.
2:45 PM	Using Simulation to Aid in the Development of a Phase II Bayesian Adaptive Design — Elizabeth Krachey, GlaxoSmithKline ; Jennifer Gauvin, GlaxoSmithKline ; Theresa C. Ashton, GlaxoSmithKline ; Ohad Amit, GlaxoSmithKline
3:05 PM	An Example of Simulation-Based Calculations of the Probability of Technical Success — Neal Thomas, Pfizer Inc.
3:25 PM	Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.